CT ScansTaichiNCT07767201
Clinical Study for Taichi Precise Image
An observational study of CT Scans and Precise Image (AI Reconstruction Feature of CT 7500 RT System), run by Philips Clinical & Medical Affairs Global.
Trial summary
The objective of the study is to evaluate the Image Quality (IQ), and diagnostic acceptability of Precise Image (PI) as compared with iDose4 as a standard-of-care reference. The study is designed to assess the performance of Precise Image algorithm on data collected from subjects scanned by CT Rembra RT, CT Areta RT… Read more about this study
- Who is it for?
- Ages 23 years and older
- Conditions the study is for
- CT Scans, Precise Image (AI Reconstruction Feature of CT 7500 RT System)
- How many people
- 192 participants
- Where
- No sites listed yet
- Study dates
- 15 Oct 2026to 31 Mar 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 23 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Subjects that are adults over the age of 22 years and scanned by CT Rembra RT, CT Areta RT or CT Rembra.
Who may be able to join
- Subjects scanned by CT Rembra RT, CT Areta RT or CT Rembra according to the department standard of care clinical protocols.
- Subjects age > twenty-two (22) years
Who cannot join
- Scans that the site radiologists/medical physicists have deemed as non-diagnostic image quality in the standard practice (e.g. patient movement)
- Scans that are not completed due to technical difficulties
About this study
The objective of the study is to evaluate the Image Quality (IQ), and diagnostic acceptability of Precise Image (PI) as compared with iDose4 as a standard-of-care reference. The study is designed to assess the performance of Precise Image algorithm on data collected from subjects scanned by CT Rembra RT, CT Areta RT or CT Rembra. This approach allows for the evaluation of image quality and diagnostic acceptability by comparing the PI algorithm with iDose4, which serves as the standard-of-care reference.
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of Precise Image reconstruction
The Image Quality and diagnostic acceptability of Precise Image reconstructions are at least as good as (non-inferior to) iDose4 for conventional images.
Measured: 5 months from enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2026
- Study start15 Oct 2026 (estimated)
- Primary completion31 Jan 2027 (estimated)
- Study completion31 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CT ScansStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 192 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07767201
- Sponsor's protocol ID
- SEF-2025-301595
- Acronym
- Taichi
- Status last verified
- Aug 2026
- First submitted
- 11 Aug 2026
- Last updated
- 17 Aug 2026
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Study for Taichi Precise Image
- ClinicalTrials.gov ID
- NCT07767201
- Acronym / sponsor ID
- Taichi / SEF-2025-301595
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 192 participants (estimated)
- Lead sponsor
- Philips Clinical & Medical Affairs GlobalIndustry (pharma, biotech, devices)
- Study start
- 15 Oct 2026 (estimated)
- Primary completion
- 31 Jan 2027 (estimated)
- Study completion
- 31 Mar 2027 (estimated)
- First posted
- 17 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of the study is to evaluate the Image Quality (IQ), and diagnostic acceptability of Precise Image (PI) as compared with iDose4 as a standard-of-care reference. The study is designed to assess the performance of Precise Image algorithm on data collected from subjects scanned by CT Rembra RT, CT Areta RT or CT Rembra. This approach allows for the evaluation of image quality and diagnostic acceptability by comparing the PI algorithm with iDose4, which serves as the standard-of-care reference.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
Who may qualify
- Ages
- 23 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Subjects that are adults over the age of 22 years and scanned by CT Rembra RT, CT Areta RT or CT Rembra.
Key inclusion criteria (2 listed)
- Subjects scanned by CT Rembra RT, CT Areta RT or CT Rembra according to the department standard of care clinical protocols.
- Subjects age > twenty-two (22) years
Key exclusion criteria (2 listed)
- Scans that the site radiologists/medical physicists have deemed as non-diagnostic image quality in the standard practice (e.g. patient movement)
- Scans that are not completed due to technical difficulties
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Acceptability of Precise Image reconstruction
Time frame: 5 months from enrollment
The Image Quality and diagnostic acceptability of Precise Image reconstructions are at least as good as (non-inferior to) iDose4 for conventional images.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2026.
Related trials for CT Scans
RecruitingPhase 2
HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
Metastatic Breast Cancer, Metastatic Solid Cancer
Recruiting
CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial
Coronary Artery Disease, Coronary Artery Bypass Grafting
Active, not recruiting
Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography
Coronary Artery Disease
Active, not recruitingPhase 3
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
Coronary Artery Disease
RecruitingObservational study
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Healthy Subjects
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of CT Scans and Precise Image (AI Reconstruction Feature of CT 7500 RT System), run by Philips Clinical & Medical Affairs Global.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of Precise Image reconstruction (time frame: 5 months from enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.